John McVey, MD
Ophthalmology · Jackson, MSNPI 1669477329
Payments from drug & device makers
Across 46 payments — averaging $35.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$658
- Amgen$253
- AbbVie$236
- Apellis Pharmaceuticals, Inc.$125
- Rxsight Inc$116
- Mallinckrodt Hospital Products Inc.$64
- plus $173 from 7 others
What the payments were for
- Food & beverage$1,626100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 11 | $658 |
| Amgen(2 entities) | 8 | $253 |
| AbbVie(2 entities) | 11 | $236 |
| Apellis Pharmaceuticals, Inc. | 1 | $125 |
| Rxsight Inc | 2 | $116 |
| Mallinckrodt Hospital Products Inc. | 3 | $64 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $38 |
| Aerie Pharmaceuticals, Inc. | 2 | $38 |
| Kala Pharmaceuticals, Inc. | 2 | $26 |
| Tarsus Pharmaceuticals, Inc. | 1 | $24 |
| Thea Pharma Inc. | 1 | $21 |
| Bausch & Lomb Americas Inc. | 1 | $14 |
| Travere Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARGOS$136
- AcrySof IQ PanOptix$128
- AcrySof$127
- Syfovre$125
- TEPEZZA$112
- TOTAL30$108
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$101
How this compares
$1,626 in reported general payments places this provider in the 45th percentile of 150 ophthalmology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Brimonidine Tartrate | 89 | $2,908 |
| Dexamethasone Sodium Phosphate | 57 | $2,491 |
| Latanoprost | 173 | $1,534 |
| ErythromycinErythromycin Base | 130 | $1,298 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 60 | $578 |
| Ciprofloxacin Hcl | 29 | $321 |
| Doxycycline Monohydrate | 14 | $237 |
| Timolol Maleate | 27 | $204 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $47 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Jackson
- Heather HancockJackson$39K
- John ShippJackson$30K
- Hongvan leJackson$27K
- Mark KoskoJackson$27K
- Kirk JeffreysJackson$9K
- Lee JonesJackson$8K
- Albert WilliamsJackson$6K
- Younghyun OhJackson$5K
- Farrah NewmanJackson$4K
- Taylor SmithJackson$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.